Maturation of resistance to lead encephalopathy: cellular and subcellular mechanisms

Neurotoxicology
|January 1, 1984
PubMed

Insights

Lead exposure in young rats causes brain damage, particularly in the cerebellum, by disrupting mitochondrial energy metabolism. Brain resistance to lead toxicity increases with age due to sequestration of lead away from mitochondria.

Area of Science:

  • Neuroscience
  • Toxicology
  • Developmental Biology

Background:

  • Lead encephalopathy in developing brains is a significant concern.
  • The developing brain exhibits age-dependent sensitivity to lead toxicity, mirroring human responses.
  • Inorganic lead exposure in rat pups serves as a model for human lead encephalopathy.

Purpose of the Study:

  • To investigate the age-dependent effects of inorganic lead on brain pathology and mitochondrial function in developing rats.
  • To elucidate the mechanisms underlying lead-induced encephalopathy and age-related resistance to lead toxicity.

Main Methods:

  • Administered inorganic lead to rat pups at different ages (from birth to 24 days) for varying durations.
  • Assessed pathological changes in the brain, including hemorrhage, edema, and neuronal necrosis.
  • Examined mitochondrial respiratory control and function in isolated cerebral and cerebellar mitochondria.
  • Investigated lead distribution in brain mitochondria using in vitro and in vivo studies, including electron microscopy and elemental microprobe analysis.

Main Results:

  • Lead exposure in early life (first two weeks) caused significant brain pathology, predominantly in the cerebellum.
  • Mitochondrial respiratory control was impaired in the cerebellum of young pups exposed to lead, with NAD-linked substrates showing inhibition.
  • Cerebral mitochondria were affected in pups exposed from birth, while adult brain mitochondria showed resistance.
  • In vitro studies indicated lead initially stimulates then inhibits mitochondrial respiration, potentially by interfering with energy metabolism and calcium binding.
  • Lead sequestration away from mitochondria correlated with age-related resistance to lead toxicity.

Conclusions:

  • Lead toxicity in the developing brain is linked to impaired cellular aerobic energy metabolism in mitochondria.
  • Age-dependent resistance to lead encephalopathy is mediated by the brain's ability to sequester lead away from critical mitochondrial sites.
  • Understanding these mechanisms is crucial for developing strategies to prevent or mitigate lead-induced neurotoxicity in children.

Related Concept Videos

Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...